BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8359803)

  • 21. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
    Cao H; Wu Z; Zhou J; Chen Z; Kuang Y
    Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for role of prostacyclin as a systemic hormone in portal hypertension.
    Sitzmann JV; Li SS; Adkinson NF
    Surgery; 1991 Feb; 109(2):149-53. PubMed ID: 1992548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced splanchnic vasoconstriction to angiotensin II in conscious rats with biliary cirrhosis.
    Braillon A; Cailmail S; Gaudin C; Lebrec D
    J Hepatol; 1993 Jan; 17(1):86-90. PubMed ID: 8445224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
    Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D
    Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Physiology of the portal system and physiopathology of portal hypertension].
    Lebrec D
    Rev Prat; 1990 Jun; 40(16):1450-3. PubMed ID: 2193365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Blocked suprahepatic pressure and the portohepatic gradient in evaluation of the portal circulation (author's transl)].
    Cortinovis A; Crippa A; Bellorini R; Pedroni G
    Chir Ital; 1980 Oct; 32(5):964-85. PubMed ID: 7018716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of circulatory dysfunction in cirrhotic portal hypertension.
    Ho HL; Huang HC
    J Chin Med Assoc; 2015 Apr; 78(4):195-203. PubMed ID: 25769934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Portal hypertension and the endothelium].
    Marecková Z; Horký K
    Cesk Fysiol; 2001 Feb; 50(1):19-24. PubMed ID: 11268558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Circulatory System in Liver Disease.
    Hollenberg SM; Waldman B
    Crit Care Clin; 2016 Jul; 32(3):331-42. PubMed ID: 27339674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research progress of vasculopathy in portal hypertension.
    Li T; Yang Z
    World J Gastroenterol; 2005 Oct; 11(39):6079-84. PubMed ID: 16273630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Circulatory hyperkinesis of cirrhosis: etiopathogenesis, clinical and therapeutic implications].
    Denie C; Henrion J
    Acta Gastroenterol Belg; 1993; 56(5-6):338-46. PubMed ID: 7511313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostacyclin and the vascular endothelium.
    Moncada S; Vane JR
    Bull Eur Physiopathol Respir; 1981; 17(4):687-701. PubMed ID: 7034824
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of vasoactive mediators in portal hypertension.
    García-Pagán JC; Bosch J; Rodés J
    Semin Gastrointest Dis; 1995 Jul; 6(3):140-7. PubMed ID: 7551971
    [No Abstract]   [Full Text] [Related]  

  • 36. Systemic hemodynamic changes in portal hypertension.
    Ready J; Rector WG
    Semin Gastrointest Dis; 1995 Jul; 6(3):134-9. PubMed ID: 7551970
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathophysiology and epidemiology of portal hypertension.
    Okumura H; Aramaki T; Katsuta Y
    Drugs; 1989; 37 Suppl 2():2-12; discussion 47. PubMed ID: 2680428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemodynamic study of portal hypertension].
    Poo JL
    Rev Gastroenterol Mex; 1994; 59(2 Suppl):65-72. PubMed ID: 8091100
    [No Abstract]   [Full Text] [Related]  

  • 39. Eicosanoids in cirrhosis and portal hypertension.
    Birney Y; Redmond EM; Sitzmann JV; Cahill PA
    Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):3-18. PubMed ID: 14626493
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.